Skip to content

BIOLARGO, INC.

BLGO

CIK 0000880242

← back to feed
Revenue (TTM)
$126.47K
+4,250.7% YoY Q1 May 2026
Net Income (TTM)
−$4.25M
−46.0% YoY Q1 May 2026
EPS Diluted (TTM)
—
Q1 May 2026
Gross Margin
2,956.4%
Q1 May 2026
Operating Margin
-11,107.5%
Q1 May 2026
Net Margin
-3,363.7%
Q1 May 2026
Free Cash Flow (TTM)
−$4.34M
Q1 May 2026
Cash
$4.12M
Q1 May 2026
Total Debt
$246K
Q1 May 2026
Shares Outstanding
320.88M sh
Q1 May 2026

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings